133 related articles for article (PubMed ID: 32732929)
1. A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors.
Wang B; Tang Q; Xu L; Teng X; Ding W; Ren G; Wang X
Mod Pathol; 2021 Jan; 34(1):42-50. PubMed ID: 32732929
[TBL] [Abstract][Full Text] [Related]
2. Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis.
Silva ANS; Coffa J; Menon V; Hewitt LC; Das K; Miyagi Y; Bottomley D; Slaney H; Aoyama T; Mueller W; Arai T; Tan IB; Deng N; Chan XB; Tan P; Tsuburaya A; Sakamaki K; Hayden JD; Yoshikawa T; Zondervan I; Savola S; Grabsch HI
Ann Surg; 2018 Jan; 267(1):114-121. PubMed ID: 27779515
[TBL] [Abstract][Full Text] [Related]
3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
4. Krukenberg tumors of gastric origin versus colorectal origin.
Jeung YJ; Ok HJ; Kim WG; Kim SH; Lee TH
Obstet Gynecol Sci; 2015 Jan; 58(1):32-9. PubMed ID: 25629016
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a Panel of Biomarkers Between Gastric Primary Cancer and the Paired Krukenberg Tumor.
Wang B; Sun K; Zou Y
Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):639-644. PubMed ID: 26945444
[TBL] [Abstract][Full Text] [Related]
6. Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH.
Das K; Gunasegaran B; Tan IB; Deng N; Lim KH; Tan P
Cancer Lett; 2014 Oct; 353(2):167-75. PubMed ID: 25086186
[TBL] [Abstract][Full Text] [Related]
7. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin.
Lin X; Han T; Zhuo M; Liu T; Liu Z; Xiang D; Li H; Xiao X
J Gastrointest Oncol; 2022 Jun; 13(3):1022-1034. PubMed ID: 35837152
[TBL] [Abstract][Full Text] [Related]
9. FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.
Su X; Zhan P; Gavine PR; Morgan S; Womack C; Ni X; Shen D; Bang YJ; Im SA; Ho Kim W; Jung EJ; Grabsch HI; Kilgour E
Br J Cancer; 2014 Feb; 110(4):967-75. PubMed ID: 24457912
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins.
Tai H; Yang Q; Wu Z; Sun S; Cao R; Xi Y; Zhao R; Zhang M; Zhang Z; Xu C
J Immunol Res; 2018; 2018():9485285. PubMed ID: 29854854
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.
Tsapralis D; Panayiotides I; Peros G; Liakakos T; Karamitopoulou E
World J Gastroenterol; 2012 Jan; 18(2):150-5. PubMed ID: 22253521
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.
Xu KY; Gao H; Lian ZJ; Ding L; Li M; Gu J
World J Surg Oncol; 2017 Jan; 15(1):25. PubMed ID: 28088224
[TBL] [Abstract][Full Text] [Related]
13. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.
Nadauld LD; Garcia S; Natsoulis G; Bell JM; Miotke L; Hopmans ES; Xu H; Pai RK; Palm C; Regan JF; Chen H; Flaherty P; Ootani A; Zhang NR; Ford JM; Kuo CJ; Ji HP
Genome Biol; 2014 Aug; 15(8):428. PubMed ID: 25315765
[TBL] [Abstract][Full Text] [Related]
14. [Study of FGFR2 status in gastric cancer by immunohistochemistry and fluorescent in situ hybridization].
Raskin GA; Mukhina MS; Kravtsova ED; Tsimafeyeu IV; Tyulandin SA; Belyak NP; Kleshchev MA; Orlova RV
Arkh Patol; 2023; 85(3):40-45. PubMed ID: 37272439
[TBL] [Abstract][Full Text] [Related]
15. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.
Stahl P; Seeschaaf C; Lebok P; Kutup A; Bockhorn M; Izbicki JR; Bokemeyer C; Simon R; Sauter G; Marx AH
BMC Gastroenterol; 2015 Feb; 15():7. PubMed ID: 25649416
[TBL] [Abstract][Full Text] [Related]
17. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
18. A comparison of HER2/neu gene amplification and its protein overexpression between primary breast cancer and metastatic lymph nodes.
Aoyama K; Kamio T; Nishikawa T; Kameoka S
Jpn J Clin Oncol; 2010 Jul; 40(7):613-9. PubMed ID: 20202990
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of HER2 gene status between primary breast cancer and synchronous axillary lymph node metastasis].
Liu YY; Wu SF; Liang ZY; Zeng X
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):393-6. PubMed ID: 27256047
[TBL] [Abstract][Full Text] [Related]
20. Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas.
Rehkaemper J; Korenkov M; Quaas A; Rueschoff J; Pamuk A; Zander T; Hillmer AM; Buettner R; Hoelscher AH; Bruns CJ; Loeser H; Alakus H; Schoemig-Markiefka B
BMC Cancer; 2020 Jun; 20(1):587. PubMed ID: 32571252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
